JUN 29, 2016 10:21 AM PDT

Mini-guts can Personalize Cystic Fibrosis Treatment

WRITTEN BY: Carmen Leitch
3 5 732
Organoids, basically a small in vitro model of an organ, could aid in identifying the best therapies for some people suffering from cystic fibrosis. A study published in Science investigated how mini-guts, simple versions of the human gut, might be used to match patients with the correct drugs, something currently possible but very time-consuming and expensive.
The response to CFTR-targeted drugs measured by swelling of intestinal organoids differs between subjects with cystic fibrosis. This material relates to a paper that appeared in the 22 June 2016, issue of Science Translational Medicine, published by AAAS. Image by Johanna Dekkers/University Medical Center Utrecht
Beginning in 2008, scientists took notice of the ability of stem cells to organize into balls of neurons that automatically organized into layers. Researchers have built on that idea ever since, attempting to grow rudimentary versions of human organs in the lab, to varying degrees of success.

Some organoids only model a snapshot of the organ during a specific time during development. Some lack certain types of cells, or do not replicate the complexity of actual organs. Already these less-than-perfect systems are providing great platforms for experiments and facilitating breakthroughs that current animal models would not have allowed for.

In this study, a research team led by Jeffrey Beekman, Associate Professor at University Medical Center Utrecht, used rectal biopsies from 71 cystic fibrosis patients to grow individual gut organoids for each patient. Those organoids' reactions to drugs targeting CFTR in vitro were closely correlated with data from clinical trials of the same drugs. The video below, from the Lancet, is about the CFTR channel.

In cystic fibrosis, mutations in the CFTR gene cause corresponding dysfunction in the CFTR protein. As a result, thick mucous builds up and clogs the lungs, pancreas and other organs of those that suffer from it. However, different gene mutations manifest differently in patients, making personalized medicine very important for these patients.

In this work, scientists followed up on their laboratory findings to take action in the clinic. The investigators selected two patients with a rare and uncharacterized mutation in their CFTR genes for a specific treatment. Following that drug therapy, both people had improved lung function and displayed fewer symptoms of disease.

The following video talks a bit about growing organoids in culture.

Sources: AAAS, Nature, Science
About the Author
  • Experienced research scientist and technical expert with authorships on 28 peer-reviewed publications, traveler to over 60 countries, published photographer and internationally-exhibited painter, volunteer trained in disaster-response, CPR and DV counseling.
You May Also Like
JUN 28, 2018
JUN 28, 2018
Synthetic T Cells the Next Big Thing in Immunotherapy
The highly complex structure and function of human T cells made the creation of synthetic versions of the immune cells difficult, but scientists from Unive
JUL 02, 2018
JUL 02, 2018
Your Brain Has an Organizational Chart
When you think about the all of the decisions we make and actions we take during an average day, the ordinary things don’t seem like much. Finding ou
JUL 05, 2018
Cell & Molecular Biology
JUL 05, 2018
Understanding the Molecular Impact of Blunt Force Trauma
Scientists want to learn more about the role of a specific protein in neurodegenerative disease that comes from impact trauma.
JUL 12, 2018
JUL 12, 2018
Why Poison Ivy Makes us Itch
For some people, summer comes with a risk of many itchy nuisances, including poison ivy.
JUL 17, 2018
Genetics & Genomics
JUL 17, 2018
CRISPR can Seriously Damage the Genome
The CRISPR/Cas9 gene-editing system took the research world by storm when it was first introduced. Now there are concerns.
JUL 25, 2018
Cell & Molecular Biology
JUL 25, 2018
Super-resolution Microscope Provides Insight Into Alzheimer's Plaques
Alzheimer's disease is the sixth leading cause of death in the US.
Loading Comments...